Evidence map›Paper›PMID 36900410›Full record

ArticleCancers2023

Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images.

Diana Veiga-Canuto, Leonor Cerdà-Alberich, Ana Jiménez-Pastor, José Miguel Carot Sierra, Armando Gomis-Maya, Cinta Sangüesa-Nebot, Matías Fernández-Patón, Blanca Martínez de Las Heras, Sabine Taschner-Mandl, Vanessa Düster and 8 more

Full text read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Applications of Artificial Intelligence for Pediatric Cancer Imaging.AJR. American journal of roentgenology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Diana Veiga-CanutoGrupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.ORCID 0000-0002-6048-2940
Leonor Cerdà-AlberichGrupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.ORCID 0000-0002-5567-4278
Ana Jiménez-PastorQuantitative Imaging Biomarkers in Medicine, QUIBIM SL, 46026 Valencia, Spain.ORCID 0000-0002-0978-9429
José Miguel Carot SierraDepartamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Camí de Vera s/n, 46022 Valencia, Spain.ORCID 0000-0001-6524-1639
Armando Gomis-MayaGrupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.ORCID 0000-0002-9527-8093
Cinta Sangüesa-NebotÁrea Clínica de Imagen Médica, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
Matías Fernández-PatónGrupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.ORCID 0000-0001-9374-1411
Blanca Martínez de Las HerasUnidad de Oncohematología Pediátrica, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
Sabine Taschner-MandlSt. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.ORCID 0000-0002-1439-5301
Vanessa DüsterSt. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.
Ulrike PötschgerSt. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.
Thorsten SimonDepartment of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0002-3425-8451
Emanuele NeriAcademic Radiology, Department of Translational Research, University of Pisa, Via Roma, 67, 56126 Pisa, Italy.ORCID 0000-0001-7950-4559
Ángel Alberich-BayarriQuantitative Imaging Biomarkers in Medicine, QUIBIM SL, 46026 Valencia, Spain.
Adela CañeteUnidad de Oncohematología Pediátrica, Hospital Universitario y Politécnico La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.
Barbara HeroDepartment of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, 50937 Cologne, Germany.
Ruth LadensteinSt. Anna Children's Cancer Research Institute, Zimmermannplatz 10, 1090 Vienna, Austria.
Luis Martí-BonmatíGrupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A 7planta, 46026 Valencia, Spain.ORCID 0000-0002-8234-010X

Funding

European Commission 826494
6 · The paper itself

Abstract

objectivesTo externally validate and assess the accuracy of a previously trained fully automatic nnU-Net CNN algorithm to identify and segment primary neuroblastoma tumors in MR images in a large children cohort.

methodsAn international multicenter, multivendor imaging repository of patients with neuroblastic tumors was used to validate the performance of a trained Machine Learning (ML) tool to identify and delineate primary neuroblastoma tumors. The dataset was heterogeneous and completely independent from the one used to train and tune the model, consisting of 300 children with neuroblastic tumors having 535 MR T2-weighted sequences (486 sequences at diagnosis and 49 after finalization of the first phase of chemotherapy). The automatic segmentation algorithm was based on a nnU-Net architecture developed within the PRIMAGE project. For comparison, the segmentation masks were manually edited by an expert radiologist, and the time for the manual editing was recorded. Different overlaps and spatial metrics were calculated to compare both masks.

resultsThe median Dice Similarity Coefficient (DSC) was high 0.997; 0.944-1.000 (median; Q1-Q3). In 18 MR sequences (6%), the net was not able neither to identify nor segment the tumor. No differences were found regarding the MR magnetic field, type of T2 sequence, or tumor location. No significant differences in the performance of the net were found in patients with an MR performed after chemotherapy. The time for visual inspection of the generated masks was 7.9 ± 7.5 (mean ± Standard Deviation (SD)) seconds. Those cases where manual editing was needed (136 masks) required 124 ± 120 s.

conclusionsThe automatic CNN was able to locate and segment the primary tumor on the T2-weighted images in 94% of cases. There was an extremely high agreement between the automatic tool and the manually edited masks. This is the first study to validate an automatic segmentation model for neuroblastic tumor identification and segmentation with body MR images. The semi-automatic approach with minor manual editing of the deep learning segmentation increases the radiologist's confidence in the solution with a minor workload for the radiologist.

Indexed as

automatic segmentationdeep learningexternal validationindependent validationneuroblastic tumorstumor segmentation

Identifiers

PMID36900410
PMCPMC10000775

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read10
table measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.